CIK 0001665988 · Accelerated filer<br>Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 810980861
- Phone
- (919) 474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- 4 Open-market sale SVP & CFO sold 5,541 shares at $5.39 ($29,853)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale SVP & General Counsel sold 3,125 shares at $5.46 ($17,063)
- 4 Open-market sale SVP & Chief Compliance Officer sold 1,217 shares at $5.46 ($6,645)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Option exercise SVP & General Counsel acquired 8,886 shares (option exercise)
- 4 Option exercise SVP & Chief Compliance Officer acquired 3,456 shares (option exercise)
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change · Regulation FD disclosure
Page 10 of 24 · 463 filings